Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O'Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA. Yung WK, et al. Among authors: yaya tur r. J Clin Oncol. 1999 Sep;17(9):2762-71. doi: 10.1200/JCO.1999.17.9.2762. J Clin Oncol. 1999. PMID: 10561351 Clinical Trial.
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM).
Balaña C, López-Pousa A, Berrocal A, Yaya-Tur R, Herrero A, García JL, Martín-Broto J, Benavides M, Cerdá-Nicolás M, Ballester R, Balart J, Capellades J. Balaña C, et al. Among authors: yaya tur r. J Neurooncol. 2004 Dec;70(3):359-69. doi: 10.1007/s11060-004-9175-1. J Neurooncol. 2004. PMID: 15662978 Clinical Trial.
Glioblastoma: changing expectations?
Arribas Alpuente L, Menéndez López A, Yayá Tur R. Arribas Alpuente L, et al. Among authors: yaya tur r. Clin Transl Oncol. 2011 Apr;13(4):240-8. doi: 10.1007/s12094-011-0648-3. Clin Transl Oncol. 2011. PMID: 21493184 Review.
[S100 protein in tumours of the central nervous system].
Ortiz-Muñoz B, Menéndez-López A, Yayá-Tur R, Arribas-Alpuente L, Maiquez-Richart J, Bordes-Monmeneu M. Ortiz-Muñoz B, et al. Among authors: yaya tur r. Rev Neurol. 2003 Jun 1-15;36(11):1011-5. Rev Neurol. 2003. PMID: 12808493 Spanish.
Durvalumab plus tremelimumab for the treatment of patients with progressive, refractory advanced thyroid carcinoma: the phase II GETNE-DUTHY trial.
Capdevila J, Hernando J, Molina-Cerillo J, Plana Serrahima M, Taberna Sanz M, Castelo B, Álvarez-Escolá C, Carmona-Bayonas A, Ballester Navarro I, Iglesias L, Bover M, Garcia-Alvarez A, Lavernia J, Yayá Tur R, Ruiz S, Baste N, Lorenzo-Lorenzo I, Sanchez-Hernandez A, Sanz-Garcia E, Marquina G, Nuciforo P, Elguero B, Grande E, Alonso-Gordoa T. Capdevila J, et al. Among authors: yaya tur r. Nat Commun. 2026 Apr 4;17(1):4891. doi: 10.1038/s41467-026-71155-y. Nat Commun. 2026. PMID: 41935063 Free PMC article. Clinical Trial.
CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.
Paz MF, Yaya-Tur R, Rojas-Marcos I, Reynes G, Pollan M, Aguirre-Cruz L, García-Lopez JL, Piquer J, Safont MJ, Balaña C, Sanchez-Cespedes M, García-Villanueva M, Arribas L, Esteller M. Paz MF, et al. Among authors: yaya tur r. Clin Cancer Res. 2004 Aug 1;10(15):4933-8. doi: 10.1158/1078-0432.CCR-04-0392. Clin Cancer Res. 2004. PMID: 15297393